Renaissance Group’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-7,943
| Closed | -$1.22M | – | 295 |
|
|
2021
Q1 | $1.22M | Buy |
7,943
+65
| +0.8% | +$9.97K | 0.05% | 139 |
|
|
2020
Q4 | $988K | Buy |
7,878
+260
| +3% | +$32.6K | 0.04% | 151 |
|
|
2020
Q3 | $773K | Buy |
7,618
+37
| +0.5% | +$3.75K | 0.04% | 151 |
|
|
2020
Q2 | $738K | Sell |
7,581
-65
| -0.9% | -$6.33K | 0.04% | 155 |
|
|
2020
Q1 | $635K | Buy |
7,646
+469
| +7% | +$39K | 0.04% | 150 |
|
|
2019
Q4 | $798K | Buy |
7,177
+2,001
| +39% | +$222K | 0.03% | 159 |
|
|
2019
Q3 | $514K | Buy |
5,176
+29
| +0.6% | +$2.88K | 0.02% | 195 |
|
|
2019
Q2 | $510K | Sell |
5,147
-79
| -2% | -$7.83K | 0.02% | 204 |
|
|
2019
Q1 | $576K | Sell |
5,226
-319
| -6% | -$35.2K | 0.02% | 182 |
|
|
2018
Q4 | $510K | Sell |
5,545
-406
| -7% | -$37.3K | 0.02% | 192 |
|
|
2018
Q3 | $656K | Buy |
5,951
+165
| +3% | +$18.2K | 0.02% | 186 |
|
|
2018
Q2 | $540K | Buy |
5,786
+373
| +7% | +$34.8K | 0.02% | 197 |
|
|
2018
Q1 | $449K | Buy |
5,413
+149
| +3% | +$12.4K | 0.02% | 205 |
|
|
2017
Q4 | $479K | Buy |
5,264
+23
| +0.4% | +$2.09K | 0.02% | 189 |
|
|
2017
Q3 | $399K | Buy |
5,241
+2
| +0% | +$152 | 0.01% | 216 |
|
|
2017
Q2 | $393K | Buy |
5,239
+126
| +2% | +$9.45K | 0.01% | 201 |
|
|
2017
Q1 | $334K | Buy |
+5,113
| New | +$334K | 0.01% | 225 |
|